Skip Navigation

Publication Detail

Title: Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics.

Authors: Uddin, Mohammad Burhan; Wang, Zhishan; Yang, Chengfeng

Published In Theranostics, (2020)

Abstract: More than a hundred chemical modifications in coding and non-coding RNAs have been identified so far. Many of the RNA modifications are dynamic and reversible, playing critical roles in gene regulation at the posttranscriptional level. The abundance and functions of RNA modifications are controlled mainly by the modification regulatory proteins: writers, erasers and readers. Modified RNA bases and their regulators form intricate networks which are associated with a vast array of diverse biological functions. RNA modifications are not only essential for maintaining the stability and structural integrity of the RNA molecules themselves, they are also associated with the functional outcomes and phenotypic attributes of cells. In addition to their normal biological roles, many of the RNA modifications also play important roles in various diseases particularly in cancer as evidenced that the modified RNA transcripts and their regulatory proteins are aberrantly expressed in many cancer types. This review will first summarize the most commonly reported RNA modifications and their regulations, followed by discussing recent studies on the roles of RNA modifications in cancer, cancer stemness as wells as functional RNA modification machinery as potential cancer therapeutic targets. It is concluded that, while advanced technologies have uncovered the contributions of many of RNA modifications in cancer, the underlying mechanisms are still poorly understood. Moreover, whether and how environmental pollutants, important cancer etiological factors, trigger abnormal RNA modifications and their roles in environmental carcinogenesis remain largely unknown. Further studies are needed to elucidate the mechanism of how RNA modifications promote cell malignant transformation and generation of cancer stem cells, which will lead to the development of new strategies for cancer prevention and treatment.

PubMed ID: 32194861 Exiting the NIEHS site

MeSH Terms: Antineoplastic Agents/pharmacology; Drug Design; Forecasting; Gene Expression Regulation, Neoplastic/genetics*; Humans; Methyltransferases/physiology; Molecular Targeted Therapy; Neoplasm Proteins/physiology; Neoplasms/drug therapy; Neoplasms/genetics*; Neoplastic Stem Cells/metabolism*; Oxidoreductases, N-Demethylating/metabolism; Pseudouridine/chemistry; Purine Nucleosides/chemistry; RNA Processing, Post-Transcriptional*/drug effects; RNA, Neoplasm/genetics*; RNA, Neoplasm/metabolism

Back
to Top